This is in contrast to a previously published model of constitutive AHR activation in which a construct lacking the PAS-B domain was expressed as a transgene under a heterologous promoter, resulting in the development stomach cancer (Andersson et al., 2002). The gene discussed is AHR; the disease is gastric cancer.